Melanocortin 1 receptor genotype: An important determinant of the damage response of melanocytes to ultraviolet radiation

FASEB Journal

Volumn 24, Issue 10, 2010, Pages 3850-3860

  Kadekaro, Ana Luisa ^a   Leachman, Sancy ^c   Kavanagh, Renny J ^a   Swope, Viki ^a   Cassidy, Pamela ^c   Supp, Dorothy ^b,d   Sartor, Maureen ^a   Schwemberger, Sandy ^b   Babcock, George ^b,d   Wakamatsu, Kazumasa ^e   Ito, Shosuke ^e   Koshoffer, Amy ^a   Boissy, Raymond E ^a   Manga, Prashiela ^f   Sturm, Richard A ^g   Abdel Malek, Zalfa A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d SHRINERS HOSPITALS FOR CHILDREN   (United States)

^e FUJITA HEALTH UNIVERSITY   (Japan)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

cAMP pathway; DNA repair; MC1R variants; Melanoma susceptibility

Indexed keywords

ALPHA MELANOCORTIN; HYDROGEN PEROXIDE; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER SUSCEPTIBILITY; DNA REPAIR; GENE EXPRESSION PROFILING; GENOMIC INSTABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION PROTECTION; SKIN PROTECTION; ULTRAVIOLET RADIATION; CELL CULTURE; GENETICS; RADIATION RESPONSE;

CELLS, CULTURED; GENOTYPE; HUMANS; MELANOCYTES; RECEPTOR, MELANOCORTIN, TYPE 1; ULTRAVIOLET RAYS;

EID: 77957856003     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-158485     Document Type: Article

References (47)

1. Purdue, M. P., Freeman, L. E., Anderson, W. F., and Tucker, M. A. (2008) Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J. Invest. Dermatol. 128, 2905-2908
2. Geller, A. C., Miller, D. R., Annas, G. D., Demierre, M. F., Gilchrest, B. A., and Koh, H. K. (2002) Melanoma incidence and mortality among US whites, 1969-1999. JAMA 288, 1719-1720
3. De Vries, E., and Coebergh, J. W. (2004) Cutaneous malignant melanoma in Europe. Eur. J. Cancer 40, 2355-2366
4. Stang, A., Pukkala, E., Sankila, R., Soderman, B., and Hakulinen, T. (2006) Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int. J. Cancer 119, 380-384 (Pubitemid 43911903)
5. Linos, E., Swetter, S. M., Cockburn, M. G., Colditz, G. A., and Clarke, C. A. (2009) Increasing burden of melanoma in the United States. J. Invest. Dermatol. 129, 1666-1674
6. Garcia-Borron, J. C., Sanchez-Laorden, B. L., and Jimenez-Cervantes, C. (2005) Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res. 18, 393-410
7. Palmer, J. S., Duffy, D. L., Box, N. F., Aitken, J. F., O'Gorman, L. E., Green, A. C., Hayward, N. K., Martin, N. G., and Sturm, R. A. (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176-186
8. Kennedy, C., ter Huurne, J., Berkhout, M., Gruis, N., Bastiaens, M., Bergman, W., Willemze, R., and Bouwes Bavinck, J. N. (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J. Invest. Dermatol. 117, 294-300
9. Smith, R., Healy, E., Siddiqui, S., Flanagan, N., Steijlen, P. M., Rosdahl, I., Jacques, J. P., Rogers, S., Turner, R., Jackson, I. J., Birch-Machin, M. A., and Rees, J. L. (1998) Melanocortin 1 receptor variants in Irish population. J. Invest. Dermatol. 111, 119-122
10. Kanetsky, P. A., Rebbeck, T. R., Hummer, A. J., Panossian, S., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Culver, H. A., Zanetti, R., Gallagher, R. P., Dwyer, T., Busam, K., From, L., Mujumdar, U., Wilcox, H., Begg, C. B., and Berwick, M. (2006) Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res. 66, 9330-9337 (Pubitemid 44521156)
11. Hunt, G., Kyne, S., Ito, S., Wakamatsu, K., Todd, C., and Thody, A. J. (1995) Eumelanin and pheomelanin contents of human epidermis and cultured melanocytes. Pigment Cell Res. 8, 202-208
12. Hennessy, A., Oh, C., Diffey, B., Wakamatsu, K., Ito, S., and Rees, J. (2005) Eumelanin and pheomelanin concentrations in human epidermis before and after UVB irradiation. Pigment Cell Res. 18, 220-223
13. Bustamante, J., Bredeston, L., Malanga, G., and Mordoh, J. (1993) Role of melanin as a scavenger of active oxygen species. Pigment Cell Res. 6, 348-353
14. 7 α-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J. Cell Sci. 107, 205-211
15. Abdel-Malek, Z., Swope, V. B., Suzuki, I., Akcali, C., Harriger, M. D., Boyce, S. T., Urabe, K., and Hearing, V. J. (1995) Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc. Natl. Acad. Sci. U. S. A. 92, 1789-1793
16. Wakamatsu, K., Graham, A., Cook, D., and Thody, A. J. (1997) Characterization of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res. 10, 288-297 (Pubitemid 127524305)
17. Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., and Cone, R. D. (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251
18. Suzuki, I., Cone, R., Im, S., Nordlund, J., and Abdel-Malek, Z. (1996) Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137, 1627-1633
19. Abdel-Malek, Z., Swope, V., Collins, C., Boissy, R., Zhao, H., and Nordlund, J. (1993) Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes. J. Cell Sci. 106, 1323-1331 (Pubitemid 24018417)
20. Im, S., Moro, O., Peng, F., Medrano, E. E., Cornelius, J., Babcock, G., Nordlund, J., and Abdel-Malek, Z. (1998) Activation of the cyclic AMP pathway by α-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res. 58, 47-54
21. Kadekaro, A. L., Kavanagh, R., Kanto, H., Terzieva, S., Hauser, J., Kobayashi, N., Schwemberger, S., Cornelius, J., Babcock, G., Shertzer, H. G., Scott, G., and Abdel-Malek, Z. A. (2005) α-Melanocortin and endothelin-1 activate anti-apoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res. 65, 4292-4299
22. Song, X., Mosby, N., Yang, J., Xu, A., Abdel-Malek, Z., Kadekaro, A. L. (2009) alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes. Pigment Cell Melanoma Res. 22, 809-818
23. Van der Velden, P. A., Sandkuijl, L. A., Bergman, W., Pavel, S., van Mourik, L., Frants, R. R., and Gruis, N. A. (2001) Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am. J. Hum. Genet. 69, 774-779
24. Box, N. F., Duffy, D. L., Chen, W., Stark, M., Martin, N. G., Sturm, R. A., and Hayward, N. K. (2001) MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am. J. Hum. Genet. 69, 765-773
25. Goldstein, A. M., Landi, M. T., Tsang, S., Fraser, M. C., Munroe, D. J., and Tucker, M. A. (2005) Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol. Biomarkers Prev. 14, 2208-2212
26. Landi, M. T., Bauer, J., Pfeiffer, R. M., Elder, D. F., Hulley, B., Minghetti, P., Calista, D., Kanetsky, P. A., Pinkel, D., and Bastian, B. C. (2006) MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313, 521-522
27. Scott, M. C., Wakamatsu, K., Ito, S., Kadekaro, A. L., Kobayashi, N., Groden, J., Kavanagh, R., Takakuwa, T., Virador, V., Hearing, V. J., and Abdel-Malek, Z. A. (2002) Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J. Cell Sci. 115, 2349-2355
28. Wang, R., Tang, P., Wang, P., Boissy, R. E., and Zheng, H. (2006) Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation. Proc. Natl. Acad. Sci. U. S. A. 103, 353-358
29. Borchers, M. T., Wesselkamper, S. C., Eppert, B. L., Motz, G. T., Sartor, M. A., Tomlinson, C. R., Medvedovic, M., and Tichelaar, J. W. (2008) Nonredundant functions of αβ and γδ T cells in acrolein-induced pulmonary pathology. Toxicol. Sci. 105, 188-199
30. McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., Jordan, S. A., Jackson, I. J., Korsmeyer, S. J., Golub, T. R., and Fisher, D. E. (2002) Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707-718
31. Wood, Z. A., Schroder, E., Robin Harris, J., and Poole, L. B. (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32-40
32. Bryk, R., Griffin, P., and Nathan, C. (2000) Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407, 211-215
33. Lovejoy, C. A., Lock, K., Yenamandra, A., and Cortez, D. (2006) DDB1 maintains genome integrity through regulation of Cdt1. Mol. Cell. Biol. 26, 7977-7990 (Pubitemid 44630997)
34. Maga, G., and Hubscher, U. (2003) Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 116, 3051-3060
35. Prosperi, E. (2006) The fellowship of the rings: distinct pools of proliferating cell nuclear antigen trimer at work. FASEB J. 20, 833-837
36. Kaldis, P., and Aleem, E. (2005) Cell cycle sibling rivalry: Cdc2 vs. Cdk2. Cell. Cycle 4, 1491-1494
37. Yamamura, K., Kamada, S., Ito, S., Nakagawa, K., Ichihashi, M., and Tsujimoto, Y. (1996) Accelerated disappearance of melanocytes in bcl-2-deficient mice. Cancer Res. 56, 3546-3550 (Pubitemid 26251651)
38. Healy, E., Jordan, S. A., Budd, P. S., Suffolk, R., Rees, J. L., and Jackson, I. J. (2001) Functional variation of MC1R alleles from red-haired individuals. Hum. Mol. Genet. 10, 2397-2402
39. Konda, Y., Gantz, I., DelValle, J., Shimoto, Y., Miwa, H., and Yamada, T. (1994) Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 269, 13162-13166
40. Park, H.-Y., Russakovsky, V., Ao, Y., Fernandez, E., and Gilchrest, B. A. (1996) Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. Exp. Cell. Res. 227, 70-79
41. McKay, B. C., Stubbert, L. J., Fowler, C. C., Smith, J. M., Cardamore, R. A., and Spronck, J. C. (2004) Regulation of ultraviolet light-induced gene expression by gene size. Proc. Natl. Acad. Sci. U. S. A. 101, 6582-6586
42. Tornaletti, S. (2005) Transcription arrest at DNA damage sites. Mutat. Res. 577, 131-145 (Pubitemid 41225493)
43. April, C. S., and Barsh, G. S. (2007) Distinct pigmentary and melanocortin 1 receptor-dependent components of cutaneous defense against ultraviolet radiation. PLoS Genet. 3, e9
44. Wei, Q., Lee, J. E., Gershenwald, J. E., Ross, M. I., Mansfield, P. F., Strom, S. S., Wang, L. E., Guo, Z., Qiao, Y., Amos, C. I., Spitz, M. R., and Duvic, M. (2003) Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J. Natl. Cancer Inst. 95, 308-315
45. Sarkar-Agrawal, P., Vergilis, I., Sharpless, N. E., DePinho, R. A., and Runger, T. M. (2004) Impaired processing of DNA photo-products and ultraviolet hypermutability with loss of p16INK4a or p19ARF. J. Natl. Cancer Inst. 96, 1790-1793
46. Bohm, M., Wolff, I., Scholsen, T. E., Robinson, S. J., Healy, E., Luger, T. A., Scharz, T., and Schwarz, A. (2005) Alpha-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem. 280, 5795-5802
47. Smith, A. G., Luk, N., Newton, R. A., Roberts, D. W., Sturm, R. A., and Muscat, G. E. (2008) Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells. J. Biol. Chem. 283, 12564-12570